Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells

Marica Rosaria Ippolito(European Institute of Oncology), Johanna Zerbib(Tel Aviv University), Yonatan Eliezer(Tel Aviv University), Eli Reuveni(Tel Aviv University), Sonia Viganò(European Institute of Oncology), Giuseppina De Feudis(European Institute of Oncology), Eldad D. Shulman(National Cancer Institute), Anouk Savir Kadmon(Tel Aviv University), Rachel Slutsky(Tel Aviv University), Tiangen Chang(National Institutes of Health), Emma M. Campagnolo(National Cancer Institute), Silvia Taglietti(European Institute of Oncology), Simone Scorzoni(European Institute of Oncology), Sara Gianotti(European Institute of Oncology), Sara Martin(European Institute of Oncology), Julia Muenzner(Charité - Universitätsmedizin Berlin), Michael Mülleder(High Throughput Biology (United States)), Nir Rozenblum(Tel Aviv University), Carmela Rubolino(Italian Institute of Technology), Tal Ben-Yishay(Tel Aviv University), Kathrin Laue(Tel Aviv University), Yael Cohen‐Sharir(Tel Aviv University), Ilaria Vigorito(Centro Cardiologico Monzino), Francesco Nicassio(Italian Institute of Technology), Eytan Ruppin(National Cancer Institute), Markus Ralser(Nuffield Orthopaedic Centre), Francisca Vázquez(Broad Institute), Stefano Santaguida(University of Milan), Uri Ben‐David(Tel Aviv University)
Cancer Discovery
September 9, 2024
Cited by 35Open Access
Full Text

Abstract

Aneuploidy results in a stoichiometric imbalance of protein complexes that jeopardizes cellular fitness. Aneuploid cells thus need to compensate for the imbalanced DNA levels by regulating their RNA and protein levels, but the underlying molecular mechanisms remain unknown. In this study, we dissected multiple diploid versus aneuploid cell models. We found that aneuploid cells cope with transcriptional burden by increasing several RNA degradation pathways, and are consequently more sensitive to the perturbation of RNA degradation. At the protein level, aneuploid cells mitigate proteotoxic stress by reducing protein translation and increasing protein degradation, rendering them more sensitive to proteasome inhibition. These findings were recapitulated across hundreds of human cancer cell lines and primary tumors, and aneuploidy levels were significantly associated with the response of patients with multiple myeloma to proteasome inhibitors. Aneuploid cells are therefore preferentially dependent on several key nodes along the gene expression process, creating clinically actionable vulnerabilities in aneuploid cells. Significance: Aneuploidy is a hallmark of cancer that is associated with poor prognosis and worse drug response. We reveal that cells with extra chromosomes compensate for their imbalanced DNA content by altering their RNA and protein metabolism, rendering them more sensitive to perturbation of RNA and protein degradation. See related commentary by Bakhoum, p. 2315.


Related Papers

No related papers found

Powered by citation graph analysis